NEW HIGHLIGHT
Cabometyx

Cabometyx Indications/Uses

cabozantinib

Manufacturer:

Ipsen Pharma

Distributor:

Zuellig Pharma
Full Prescribing Info
Indications/Uses
Renal Cell Carcinoma (RCC): CABOMETYX is indicated for the treatment of advanced renal cell carcinoma (RCC): in treatment-naïve adults with intermediate or poor risk (see Pharmacology: Pharmacodynamics under Actions); in adults following prior vascular endothelial growth factor (VEGF)-targeted therapy.
Hepatocellular Carcinoma (HCC): CABOMETYX is indicated as monotherapy for the treatment of hepatocellular carcinoma (HCC) in adults who have previously been treated with sorafenib.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in